Johnson & Johnson COVID vaccine cleared for expected FDA authorization within days
Published
If the FDA agrees with its review panel, as expected, the one-dose vaccine could begin rolling out to the American public next week.
Published
If the FDA agrees with its review panel, as expected, the one-dose vaccine could begin rolling out to the American public next week.
It is the first single-dose COVID-19 vaccine available in the U.S. and is one that "checks nearly all the boxes."
Watch VideoThe FDA has approved the Johnson & Johnson COVID-19 vaccine for emergency use.
J&J says its COVID-19..